Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1992-5-15
pubmed:abstractText
The two subunits of the human class I histocompatibility antigen (HLA)-A2 have been expressed at high levels (20-30 mg/liter) as insoluble aggregates in bacterial cells. The aggregates were dissolved in 8 M urea and then refolded to form an HLA-A2-peptide complex by removal of urea in the presence of an antigenic peptide. Two peptides from the matrix protein and nucleoprotein of influenza virus are known to bind to HLA-A2, and both support the refolding of the recombinant HLA-A2 molecule. An additional peptide, a nonamer from the gp120 envelope protein of human immunodeficiency virus type 1, also supported refolding. Yields of purified recombinant HLA-A2 are 10-15%. In the absence of an HLA-A2-restricted peptide, a stable HLA-A2 complex was not formed. Monoclonal antibodies known to bind to native HLA-A2 also bound to the recombinant HLA-A2-peptide complex. Three purified HLA-A2-peptide complexes refolded from bacterially produced protein aggregates crystallize under the identical conditions as HLA-A2 purified from human lymphoblastoid cells. Crystals of the recombinant HLA-A2 molecule in complex with the influenza matrix nonamer peptide, Mp(58-66), diffract to greater than 1.5-A resolution.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1369317, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1553383, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1709722, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1717555, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1721637, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1922337, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-1922338, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2017257, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2038058, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2367533, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2408046, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2437457, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2443855, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2451830, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2469442, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2480387, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2594067, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-2687112, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-3309677, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-3323806, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-3760563, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-3878413, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-4129801, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-4514327, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-6189821, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-6190942, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-667938, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-6982419, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-714164, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-72068, http://linkedlifedata.com/resource/pubmed/commentcorrection/1565634-781677
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3429-33
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed-meshheading:1565634-Amino Acid Sequence, pubmed-meshheading:1565634-Antibodies, Monoclonal, pubmed-meshheading:1565634-Base Sequence, pubmed-meshheading:1565634-Cloning, Molecular, pubmed-meshheading:1565634-Crystallization, pubmed-meshheading:1565634-Escherichia coli, pubmed-meshheading:1565634-HIV Envelope Protein gp120, pubmed-meshheading:1565634-HLA-A2 Antigen, pubmed-meshheading:1565634-Humans, pubmed-meshheading:1565634-Macromolecular Substances, pubmed-meshheading:1565634-Molecular Sequence Data, pubmed-meshheading:1565634-Nucleoproteins, pubmed-meshheading:1565634-Oligodeoxyribonucleotides, pubmed-meshheading:1565634-Peptides, pubmed-meshheading:1565634-Plasmids, pubmed-meshheading:1565634-Polymerase Chain Reaction, pubmed-meshheading:1565634-Protein Binding, pubmed-meshheading:1565634-Protein Conformation, pubmed-meshheading:1565634-Protein Denaturation, pubmed-meshheading:1565634-Recombinant Proteins, pubmed-meshheading:1565634-Restriction Mapping, pubmed-meshheading:1565634-Viral Matrix Proteins, pubmed-meshheading:1565634-Viral Proteins
pubmed:year
1992
pubmed:articleTitle
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.
pubmed:affiliation
Department of Biochemistry and Molecular Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138-2092.
pubmed:publicationType
Journal Article
More...